Welcome to the e-CCO Library Archive!

Filter:
N010

Flowchart-based monitoring of IBD patients on biological treatment

Authors:

Y. Krogager*, L. Neergaard

Herlev Sygehus, Gastroenterology, Herlev, Denmark

N011.

Therapeutic drug monitoring of thiopurine metabolites in patients with inflammatory bowel disease (IBD) in a Dutch peripheral hospital. Indications and therapeutic consequences

Authors:

R. Theeuwen1, M. Alleman1, S. Abraham1, R. Ong2, M. Vu1, 1Rijnland Hospital, Gastroenterology, Leiderdorp, Netherlands, 2University of Applied Sciences, Epidemiology, Leiden, Netherlands

N011. A comparison of gastroenterology and non-gastroenterology nurses' knowledge of inflammatory bowel disease
Authors:

M. Sephton1, S. Tattersall2, K. Kemp3, A. Hurst4, L. Gray5, B. Gregg6, T. Law7, L. Parkinson8, V. Hall2, 1University Hospital South Manchester, Gastroenterology, Manchester, United Kingdom, 2Royal Bolton Hospital, Gastroenterology, Greater Manchester, United Kingdom, 3Manchester University, Nursing Department, Manchester, United Kingdom, 4University Hospital Aintree, Gastroenterology, Liverpool, United Kingdom, 5Countess of Chester Hospital, Gastroenterology, Chester, United Kingdom, 6Royal Liverpool & Broadgreen University Hospitals, Gastroenterology, Liverpool, United Kingdom, 7Pennine Acute Trust, Gastroenterology, Greater Manchester, United Kingdom, 8Blackpool Teaching Hospitals, Gastroenterology, Blackpool, United Kingdom

N012.

Role of ambulatory nursery patient education in adalimumab therapy

Authors:

N. Cano, L. Oltra, M. Sanz, J. Hinojosa, Hospital de Manises, IBD unit, Manises, Spain

N012. The value and feedback of an open information event for those affected by inflammatory bowel disease
Authors:

H. Middleton1, M. O'Connor1, T. Tyrrell1, 1St Mark's Hospital, IBD Unit, Middlesex, United Kingdom

N013.

Experience with metronidazole topical therapy to treat dermatological lesions related to inflammatory bowel disease (IBD)

Authors:

M.C. Morete Pérez1, R. Fraga Iriso1, L. Fúster Sanjurjo2, A. Echarri Piudo1, 1Complejo Hospitalario Universitario de Ferrol, IBD Unit. Gastroenterology, Ferrol, Spain, 2Complejo Hospitalario Universitario de Ferrol, Pharmacy Service, Ferrol, Spain

N013. Progressive reduction of infusion time of Infliximab. Experience in day-hospital
Authors:

L. Oltra1, N. Cano1, E. Martín2, E. Hinojosa1, J. Hinojosa1, 1Manises Hospital, Inflammatory Bowel Disease Unit – Day Hospital, Manises, Spain, 2University General Hospital, Valencia, Spain

N014. How fatigue is experienced and handled by female patients with inflammatory bowel disease (IBD)
Authors:

A. Beck1, P. Bager1, P.E. Jensen2, 1Aarhus University Hospital, Department of Medicine V (Hepatology and Gastroenterology), Aarhus C, Denmark, 2VIA University College, Education of nurses, Aarhus, Denmark

N015. Patient education on their disease as a determinant on the progression of complications. The role of specialized nursing
Authors:

M. Morete1, J.A. Rodriguez1, M. Figueira1, A. Echarri1, 1Hospital A. Marcide, Gastroenterology, Ferrol, Spain

NEW FRONTIERS IN SMALL BOWELL PATHOLOGY: THE ROLE OF SPIRAL ENTEROSCOPY
Source: ESGE Abstract 2013
Authors: Teodora Atena Pop1,2, Ofelia Mosteanu 1 ,2, Marcel Tantau1,2 „Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania Regional Institute of Gastroenterology and Hepatology „Prof.Dr.O.Fodor” Cluj-Napoca, Romania
NO001.

Self-care among patients with inflammatory bowel disease – an interview study

Authors:

U. Lovén Wickman1,2, P. Yngman Uhlin1, H. Hjortswang3, B.J. Riegel4, H. Stjernman5, G. Hollman Frisman1,6, 1University of Linköping, Department of Medical and Health Sciences, Division of Nursing Sciences, Linköping, Sweden, 2County Council of Kalmar, Health centre, Blomstermåla, Sweden, 3County Council of Östergötland and University of Linköping, Department of Clinical and Experimental Medicine, Division for Gastroenterology, Linköping, Sweden, 4University of Pennsylvania, School of Nursing, Pennsylvania, United States, 5County Council of Jönköping, Department of Medicine, County Hospital Ryhov, Jönköping, Sweden, 6County Council of Östergötland, Anaesthetics, Operations and Speciality Surgery Centre, Linköping, Sweden

NO001

Application of a Japanese version of the morisky medication adherence scale and related factors to low medication adherence in patient with Ulcerative Colitis

Authors:

A. Kawakami*1, M. Tanaka2, N. Yamamoto-Mitani3, N. Yoshimura4, R. Suzuki5, S. Maeda6, R. Kunisaki1

1Yokohama City University Medical Centre, Inflammatory Bowel Disease Centre, Yokohama, Japan, 2Mahidol University, Faculty of Medicine Ramatibodi Hospital, Ramatibodi School of Nursing, Bangkok, Thailand, 3The University of Tokyo, School of Health Sciences and Nursing, Tokyo, Japan, 4Social Insurance Central General Hospital, Inflammatory Bowel Disease Centre, Tokyo, Japan, 5Kannai Suzuki Clinic, Division of Gastroenterology, Yokohama, Japan, 6Yokohama City University Graduate School of Medicine, Department of Gastroenterology, Yokohama, Japan

NO002.

Symptom burden in individuals with inflammatory bowel disease: A mixed methods study

Authors:

D. Farrell, E. Savage, G. McCarthy, University College Cork, School of Nursing and Midwifery, Cork, Ireland

NO002

Assessing the satisfaction levels of older patients with different types of follow-up care for inflammatory bowel disease

Authors:

L. Younge*1, J. Lindsay1, L. Langmead1, W. Czuber - Dochan2

1Barts Health, IBD, London, United Kingdom, 2KCL, School of Nursing, London, United Kingdom

NO003.

Development of an assessment method based on Health Belief Model to identify patients with ulcerative colitis at high risk of non-adherence to aminosalicylates

Authors:

A. Kawakami1, M. Tanaka2, M. Nishigaki2, N. Yamamoto-Mitani2, N. Yoshimura3, R. Suzuki4, S. Maeda5, R. Kunisaki1, 1Yokohama City University Medical centre, IBD Centre, Yokohama, Japan, 2The Univercity of Tokyo, School of Health Sciences and Nursing, Tokyo, Japan, 3Social Insurance Central General Hospital, IBD Centre, Tokyo, Japan, 4Kannai Suzuki Clinic, Division of Gastroenterology, Yokohama, Japan, 5Yokohama City University Graduate School of Medicine, Department of Gastroenterology, Yokohama, Japan

NO003

Development of a Web-based application to improve quality of life in IBD patients.

Authors:

F. Murciano Gonzalo*1, I. A. Ibañez Zafón1, M. Gallego Barrero2, Pilar González Gálvez3

1Hospital del Mar, Gastroenterology, Barcelona, Spain, 2Hospital Clínic , Gastroenterology, Barcelona, Spain, 3Blanquerna - Universitat Ramon Llull, School of Nursing, Barcelona, Spain

OBESITY AND OUTCOME OF RECTOCUTANEOUS FISTULA SURGERY IN PATIENTS WITH CROHN’S
Source: ESGE Abstract 2013
Authors: Talha A. Malik MD, MSPH, Ioana B. Smith MD, Jeffrey Juneau MD, Ali S. Khan, MD, Ashish Manne MD, Gerald McGwin, PhD, Fred H. Weber, MD
OBSCURE GASTROINTESTINAL BLEEDING: COMPARING SPIRAL ENTEROSCOPY AND CT ENTEROGRAPHY
Source: ESGE Abstract 2013
Authors: Ofelia Mosteanu1,2 , Teodora Atena Pop 1 ,2, Adrian Mucileanu1, Ofelia Anton2, Marcel Tantau1,2 1. „Iuliu Hatieganu” University of Medicine and Pharmacy Cluj-Napoca, Romania 2. Regional Institute of Gastroenterology and Hepatology „Prof.Dr.O.Fodor” Cluj-Napoca, Romania
Olmesartan Induced Enteropathy-Not all villous atrophy is Celiac disease
Source: ESGE Abstract 2013
Authors: Ali Safdar Khan1, Shajan Peter1, Klaus Mönkemüller1, C. Mel Wilcox1 1Division of Gastroenterology and Hepatology, University of Alabama at Birmingham
ON001. An investigation of the manifestations of perceived psychological stress in patients with inflammatory bowel disease
Authors:

K. Sugrue1, M. Landers2, J. McCarthy1, M. Buckley1, 1Mercy University Hospital, Gastroenterology, Cork, Ireland, 2University College Cork, Cork, Ireland